The Board of Directors of the Company('Board') at its meeting held on 23 June 2023, inter-alia considered and approved the following business items: 1. Increase of Authorized Share Capital 2. Rights issue 3. Approval of Scheme of Amalgamation with Shilpa Therapeutics Private Limited (A Wholly Owned Subsidiary Company).